Alysson Muotri is professor of pediatrics and of cellular and molecular medicine at the University of California, San Diego. He also co-directs the Stem Cell Program at the university’s Moores Cancer Center.
Alysson Muotri
Associate professor
University of California, San Diego
From this contributor
With tweaks, brains in a dish may yield clear clues to autism
‘Mini-brains’ created in a dish may reveal autism’s roots and point to treatments, but they do not yet mirror some critical features of a human brain.
With tweaks, brains in a dish may yield clear clues to autism
By
Alysson Muotri
21 March 2017 | 5 min read
Questions for Alysson Muotri: Applying autism tools to Zika
Mini-brains grown from stem cells in culture can reveal the effects of both autism and the Zika virus on early development.
Questions for Alysson Muotri: Applying autism tools to Zika
By
Jessica Wright
14 June 2016 | 6 min read
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read